https://corcept.com/wp-content/uploads/COR-logo.svg00jeremiah@devisedesigns.comhttps://corcept.com/wp-content/uploads/COR-logo.svgjeremiah@devisedesigns.com2018-09-19 00:00:002018-09-19 00:00:00Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
